Clinical trials for coronavirus disease 2019: What is being evaluated and what is not

Yaseen Arabi; Ayed Asseri; Steve Webb; John Marshall; Mohamed Al Moamary

doi:10.4103/atm.ATM_99_20

Clinical trials for coronavirus disease 2019: What is being evaluated and what is not

Yaseen Arabi, Ayed Asseri, Steve Webb, John Marshall, Mohamed Al Moamary

Research output: Contribution to journal › Comment / Debate › Other › peer-review

7 Citations (Scopus)

Abstract

Since the report of the first case of coronavirus disease 2019 (COVID-19) in China in late December 2019, there have been 204 610 cases worldwide as of 18 March, 2020. As part of the response to this outbreak, there has been an impressive amount of research undertaken to better characterize the disease and to evaluate therapeutic options. By March 12, 2020, there are more than 382 studies registered in the clinical trials databases addressing COVID-19 including more than 80 randomized controlled trials.

Original language	English
Pages (from-to)	49-51
Number of pages	3
Journal	Annals of Thoracic Medicine
Volume	15
Issue number	2
DOIs	https://doi.org/10.4103/atm.ATM_99_20
Publication status	Published - 1 Apr 2020

Keywords

Clinical trials
coronavirus disease 2019
outbreak response

Access to Document

10.4103/atm.ATM_99_20Licence: CC BY-NC-SA

Cite this

@article{a2d6d123a9cc4172a0c7d887c9bc88df,

title = "Clinical trials for coronavirus disease 2019: What is being evaluated and what is not",

abstract = "Since the report of the first case of coronavirus disease 2019 (COVID-19) in China in late December 2019, there have been 204 610 cases worldwide as of 18 March, 2020. As part of the response to this outbreak, there has been an impressive amount of research undertaken to better characterize the disease and to evaluate therapeutic options. By March 12, 2020, there are more than 382 studies registered in the clinical trials databases addressing COVID-19 including more than 80 randomized controlled trials.",

keywords = "Clinical trials, coronavirus disease 2019, outbreak response",

author = "Yaseen Arabi and Ayed Asseri and Steve Webb and John Marshall and \{Al Moamary\}, Mohamed",

note = "Publisher Copyright: {\textcopyright} 2020 Journal of Research in Pharmacy Practice - Published by Wolters Kluwer - Medknow.",

year = "2020",

month = apr,

day = "1",

doi = "10.4103/atm.ATM\_99\_20",

language = "English",

volume = "15",

pages = "49--51",

journal = "Annals of Thoracic Medicine",

issn = "1817-1737",

publisher = "Medknow Publications",

number = "2",

}

TY - JOUR

T1 - Clinical trials for coronavirus disease 2019

T2 - What is being evaluated and what is not

AU - Arabi, Yaseen

AU - Asseri, Ayed

AU - Webb, Steve

AU - Marshall, John

AU - Al Moamary, Mohamed

PY - 2020/4/1

Y1 - 2020/4/1

N2 - Since the report of the first case of coronavirus disease 2019 (COVID-19) in China in late December 2019, there have been 204 610 cases worldwide as of 18 March, 2020. As part of the response to this outbreak, there has been an impressive amount of research undertaken to better characterize the disease and to evaluate therapeutic options. By March 12, 2020, there are more than 382 studies registered in the clinical trials databases addressing COVID-19 including more than 80 randomized controlled trials.

AB - Since the report of the first case of coronavirus disease 2019 (COVID-19) in China in late December 2019, there have been 204 610 cases worldwide as of 18 March, 2020. As part of the response to this outbreak, there has been an impressive amount of research undertaken to better characterize the disease and to evaluate therapeutic options. By March 12, 2020, there are more than 382 studies registered in the clinical trials databases addressing COVID-19 including more than 80 randomized controlled trials.

KW - Clinical trials

KW - coronavirus disease 2019

KW - outbreak response

UR - http://www.scopus.com/inward/record.url?scp=85083247276&partnerID=8YFLogxK

U2 - 10.4103/atm.ATM_99_20

DO - 10.4103/atm.ATM_99_20

M3 - Comment / Debate

C2 - 32489437

AN - SCOPUS:85083247276

SN - 1817-1737

VL - 15

SP - 49

EP - 51

JO - Annals of Thoracic Medicine

JF - Annals of Thoracic Medicine

IS - 2

ER -

Clinical trials for coronavirus disease 2019: What is being evaluated and what is not

Abstract

Keywords

Access to Document

Other files and links

Cite this